Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.
about
Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled TrialsAssociation of serum uric acid level with mortality and morbidity of patients with acute ST-elevation myocardial infarction.Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionComparative metabonomics of Wenxin Keli and Verapamil reveals differential roles of gluconeogenesis and fatty acid β-oxidation in myocardial injury protection.Waking up the stem cell niche: how hematopoietic stem cells generate inflammatory monocytes after stroke.
P2860
Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nonantithrombotic medical opti ...... and new lines on the horizon.
@ast
Nonantithrombotic medical opti ...... and new lines on the horizon.
@en
type
label
Nonantithrombotic medical opti ...... and new lines on the horizon.
@ast
Nonantithrombotic medical opti ...... and new lines on the horizon.
@en
prefLabel
Nonantithrombotic medical opti ...... and new lines on the horizon.
@ast
Nonantithrombotic medical opti ...... and new lines on the horizon.
@en
P2093
P2860
P1433
P1476
Nonantithrombotic medical opti ...... and new lines on the horizon.
@en
P2093
Patrick T O'Gara
Victor Soukoulis
William E Boden
P2860
P304
P356
10.1161/CIRCRESAHA.114.302804
P577
2014-06-01T00:00:00Z